Sort
64,565 grants matching “drug discovery”
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal
$711,750David S Stephens · Emory University · KL2 · FY2014 · TR
Using Integrative Genomics To Identify and Characterize Emphysema-Associated eQTL
$711,689Peter Castaldi · Brigham And Women'S Hospital · R01 · FY2024 · HL
Emerging virus-host cell protein interaction networks
$711,675Douglas J. Lacount · Purdue University · R01 · FY2019 · AI
Novel mouse models of hepatitis B virus infection and replication
$711,641Guangxiang George Luo · Wake Forest University Health Sciences · R01 · FY2025 · AI
Defining the Inflammation and Immunity Transcriptome in Severe Malarial Anemia for Immunotherapeutic Discovery
$711,525Douglas Jay Perkins · University Of New Mexico Health Scis Ctr · R01 · FY2020 · AI
Development and Testing of New Computational Methods for Ligand Discovery and Mechanism
$711,494Brian K. Shoichet · University Of California, San Francisco · R35 · FY2017 · GM
Genetic and Clinical Predictors of Response to Warfarin and Novel Anticoagulants
$711,488Nita A Limdi · University Of Alabama At Birmingham · R01 · FY2018 · HL
Small molecule Hsp90 inhibitors in AD treatment
$711,474Gabriela Chiosis · Sloan-Kettering Inst Can Research · U01 · FY2011 · AG
Discovery of Novel Benzimidazole Resistance Mechanisms
$711,434Erik Christian Andersen · Johns Hopkins University · R01 · FY2023 · AI
Development and Prevention of Substance Abuse Problems
$711,409Kenneth A Dodge · Duke University · R01 · FY2011 · DA
Automated Literature Mining for Validation of High-Throughput Function Prediction
$711,389Lawrence E Hunter · University Of Colorado Denver · R01 · FY2010 · LM
High-yield production of GDP-fucose for fucosylation of molecules
$711,370Leila Aminova · Zuchem, Inc. · R44 · FY2015 · GM
Highly Multiplexed Cell-Based GPCR Assay.
$711,325G. Reid Asbury · Spectragenetics · R44 · FY2022 · MH
A scalable system for high-throughput and longitudinal electrophysiology in rodent brain research
$711,310Mattias Peter Karlsson · Spikegadgets, Llc · R44 · FY2019 · MH
Contribution of Stress Induced Autonomic and Urothelial Dysregulation to IC/BPS
$711,234Lori A Birder · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · DK
Genetic and Clinical Predictors of Response to Warfarin and Novel Anticoagulants
$711,004Nita A Limdi · University Of Alabama At Birmingham · R01 · FY2017 · HL
Functional consequences of cancer mutations
$710,952Chris Sander · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA
Glutamate reducing interventions in schizophrenia
$710,930Scott A Small · Columbia University Health Sciences · R61 · FY2018 · MH
technologyIn vitro maturation of BMP-7-responsive pancraeatic beta cell progenitors by oxygen modulation
$710,890Paul Latta · Ophysio, Inc. · R44 · FY2017 · DK
Optimizing Beta-Adrenoceptor Signaling Bias in Asthma
$710,814Julia K L Walker · Duke University · R01 · FY2014 · AI
Neonatal Opioid Exposure and Withdrawal: Molecular and Behavioral Consequences
$710,780Julie A Blendy · University Of Pennsylvania · R01 · FY2020 · DA
Evolving understanding of HIV-1 reverse transcriptase structure, function, and inhibition.
$710,724Edward V Arnold · Rutgers, The State Univ Of N.J. · R01 · FY2021 · AI
Development of neutral sphingomyelinase 2 (nSMase2) inhibitors for the treatment of Alzheimer's disease
$710,695Takashi Tsukamoto · Johns Hopkins University · R01 · FY2025 · AG
Highly Specific ZFN-Based HSC Gene Editing Therapies Identified By In Vivo Barcode Nanoparticle Screens And Rationally Designed Mrna
$710,671James Dahlman · Georgia Institute Of Technology · UG3 · FY2019 · TR
Gene to Phenotype Networks for Alcohol & Drug Addiction
$710,619Daniel Goldowitz · University Of British Columbia · R01 · FY2008 · DA